Puneet Opal, MD, PhD

Northwestern University, Evanston, IL 
Neurodegeneration, Neurology
"Puneet Opal"
Mean distance: 16.29 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hu YS, Do J, Edamakanti CR, et al. (2019) Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1. Brain : a Journal of Neurology
Sun X, Lu B, Han C, et al. (2017) ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia. Blood Cancer Journal. 7: 661
Cvetanovic M, Hu YS, Opal P. (2016) Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1. Cerebellum (London, England)
Lowery J, Jain N, Kuczmarski ER, et al. (2015) Abnormal Intermediate Filament Organization Alters Mitochondrial Motility in Giant Axonal Neuropathy Fibroblasts. Molecular Biology of the Cell
Dell'Orco JM, Wasserman AH, Chopra R, et al. (2015) Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 11292-307
Cvetanovic M, Ingram M, Orr H, et al. (2015) Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience. 289: 289-99
Rozenfeld MN, Nemeth AJ, Walker MT, et al. (2015) An investigation of diffusion imaging techniques in the evaluation of spinocerebellar ataxia and multisystem atrophy. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 166-72
Venkatraman A, Hu YS, Didonna A, et al. (2014) The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Human Molecular Genetics. 23: 3733-45
Opal P, Orr HT. (2014) Animal Models of Spinocerebellar Ataxia Type 1 Movement Disorders: Genetics and Models: Second Edition. 979-990
Mahammad S, Murthy SN, Didonna A, et al. (2013) Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. The Journal of Clinical Investigation. 123: 1964-75
See more...